Drug discovery and development company Roche and bioinformatics company PathAI have partnered to allow PathAI to work exclusively with Roche Tissue Diagnostics to create AI-driven digital pathology algorithms for CDx tools. The image analysis algorithms resulting from this partnership will be deployed through Roche's Navify digital pathology solution.
The exclusivity of the partnership would last a specified period, during which PathAI will be the only external company developing AI-based algorithms for Roche Tissue Diagnostics in the CDx tools field. According to the partnership terms, Roche would continue its own algorithm development for CDx tools, while PathAI can pursue algorithm development outside of this realm.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.